Human cytomegalovirus UL97 kinase activity is required for the hyperphosphorylation of retinoblastoma protein and inhibits the formation of nuclear aggresomes. 2008

Mark N Prichard, and Elizabeth Sztul, and Shannon L Daily, and Amie L Perry, and Samuel L Frederick, and Rachel B Gill, and Caroll B Hartline, and Daniel N Streblow, and Susan M Varnum, and Richard D Smith, and Earl R Kern
Department of Pediatrics, University of Alabama School of Medicine, Birmingham, Alabama 35233, USA. mprichard@peds.uab.edu

Cells infected with human cytomegalovirus in the absence of UL97 kinase activity produce large nuclear aggregates that sequester considerable quantities of viral proteins. A transient expression assay suggested that pp71 and IE1 were also involved in this process, and this suggestion was significant, since both proteins have been reported to interact with components of promyelocytic leukemia (PML) bodies (ND10) and also interact functionally with retinoblastoma pocket proteins (RB). PML bodies have been linked to the formation of nuclear aggresomes, and colocalization studies suggested that viral proteins were recruited to these structures and that UL97 kinase activity inhibited their formation. Proteins associated with PML bodies were examined by Western blot analysis, and pUL97 appeared to specifically affect the phosphorylation of RB in a kinase-dependent manner. Three consensus RB binding motifs were identified in the UL97 kinase, and recombinant viruses were constructed in which each was mutated to assess a potential role in the phosphorylation of RB and the inhibition of nuclear aggresome formation. The mutation of either the conserved LxCxE RB binding motif or the lysine required for kinase activity impaired the ability of the virus to stabilize and phosphorylate RB. We concluded from these studies that both UL97 kinase activity and the LxCxE RB binding motif are required for the phosphorylation and stabilization of RB in infected cells and that this effect can be antagonized by the antiviral drug maribavir. These data also suggest a potential link between RB function and the formation of aggresomes.

UI MeSH Term Description Entries
D008856 Microscopy, Fluorescence Microscopy of specimens stained with fluorescent dye (usually fluorescein isothiocyanate) or of naturally fluorescent materials, which emit light when exposed to ultraviolet or blue light. Immunofluorescence microscopy utilizes antibodies that are labeled with fluorescent dye. Fluorescence Microscopy,Immunofluorescence Microscopy,Microscopy, Immunofluorescence,Fluorescence Microscopies,Immunofluorescence Microscopies,Microscopies, Fluorescence,Microscopies, Immunofluorescence
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D002853 Chromatography, Liquid Chromatographic techniques in which the mobile phase is a liquid. Liquid Chromatography
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland

Related Publications

Mark N Prichard, and Elizabeth Sztul, and Shannon L Daily, and Amie L Perry, and Samuel L Frederick, and Rachel B Gill, and Caroll B Hartline, and Daniel N Streblow, and Susan M Varnum, and Richard D Smith, and Earl R Kern
January 2003, Journal of virology,
Mark N Prichard, and Elizabeth Sztul, and Shannon L Daily, and Amie L Perry, and Samuel L Frederick, and Rachel B Gill, and Caroll B Hartline, and Daniel N Streblow, and Susan M Varnum, and Richard D Smith, and Earl R Kern
July 2003, Journal of virology,
Mark N Prichard, and Elizabeth Sztul, and Shannon L Daily, and Amie L Perry, and Samuel L Frederick, and Rachel B Gill, and Caroll B Hartline, and Daniel N Streblow, and Susan M Varnum, and Richard D Smith, and Earl R Kern
November 2022, The Journal of biological chemistry,
Mark N Prichard, and Elizabeth Sztul, and Shannon L Daily, and Amie L Perry, and Samuel L Frederick, and Rachel B Gill, and Caroll B Hartline, and Daniel N Streblow, and Susan M Varnum, and Richard D Smith, and Earl R Kern
December 2005, Journal of virology,
Mark N Prichard, and Elizabeth Sztul, and Shannon L Daily, and Amie L Perry, and Samuel L Frederick, and Rachel B Gill, and Caroll B Hartline, and Daniel N Streblow, and Susan M Varnum, and Richard D Smith, and Earl R Kern
September 2009, Proceedings of the National Academy of Sciences of the United States of America,
Mark N Prichard, and Elizabeth Sztul, and Shannon L Daily, and Amie L Perry, and Samuel L Frederick, and Rachel B Gill, and Caroll B Hartline, and Daniel N Streblow, and Susan M Varnum, and Richard D Smith, and Earl R Kern
October 2011, Antimicrobial agents and chemotherapy,
Mark N Prichard, and Elizabeth Sztul, and Shannon L Daily, and Amie L Perry, and Samuel L Frederick, and Rachel B Gill, and Caroll B Hartline, and Daniel N Streblow, and Susan M Varnum, and Richard D Smith, and Earl R Kern
May 2013, Journal of virology,
Mark N Prichard, and Elizabeth Sztul, and Shannon L Daily, and Amie L Perry, and Samuel L Frederick, and Rachel B Gill, and Caroll B Hartline, and Daniel N Streblow, and Susan M Varnum, and Richard D Smith, and Earl R Kern
January 1997, Journal of virology,
Mark N Prichard, and Elizabeth Sztul, and Shannon L Daily, and Amie L Perry, and Samuel L Frederick, and Rachel B Gill, and Caroll B Hartline, and Daniel N Streblow, and Susan M Varnum, and Richard D Smith, and Earl R Kern
August 1999, Antimicrobial agents and chemotherapy,
Mark N Prichard, and Elizabeth Sztul, and Shannon L Daily, and Amie L Perry, and Samuel L Frederick, and Rachel B Gill, and Caroll B Hartline, and Daniel N Streblow, and Susan M Varnum, and Richard D Smith, and Earl R Kern
January 2014, Journal of virology,
Copied contents to your clipboard!